These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19203339)

  • 21. Health workers' support for hepatitis C treatment uptake among clients with a history of injecting.
    Brener L; von Hippel C; Wilson H; Hopwood M
    J Health Psychol; 2018 Jul; 23(8):1012-1018. PubMed ID: 27098384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of physician and nurse attitudes in the health care of injecting drug users.
    Brener L; Von Hippel W; Kippax S; Preacher KJ
    Subst Use Misuse; 2010 Jun; 45(7-8):1007-18. PubMed ID: 20441447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia.
    Keats J; Micallef M; Grebely J; Hazelwood S; Everingham H; Shrestha N; Jones T; Bath N; Treloar C; Dore GJ; Dunlop A;
    Int J Drug Policy; 2015 Oct; 26(10):999-1006. PubMed ID: 26275578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Australian Treatment Outcomes Profile instrument as a clinical tool for older alcohol and other drug clients: A validation study.
    Lintzeris N; Monds LA; Rivas G; Leung S; Withall A; Draper B
    Drug Alcohol Rev; 2016 Nov; 35(6):673-677. PubMed ID: 27072851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders.
    Rosenberg SD; Drake RE; Brunette MF; Wolford GL; Marsh BJ
    AIDS; 2005 Oct; 19 Suppl 3():S26-33. PubMed ID: 16251824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Residential substance user treatment programs as venues for HCV pharmacological treatment: client and staff perspectives.
    Strauss SM; Astone JM; Munoz-Plaza C; Hagan H; Des Jarlais D
    Subst Use Misuse; 2005; 40(12):1811-29. PubMed ID: 16419558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A qualitative study trialling the acceptability of new hepatitis C prevention messages for people who inject drugs: symbiotic messages, pleasure and conditional interpretations.
    Treloar C; Newland J; Maher L
    Harm Reduct J; 2015 Mar; 12():5. PubMed ID: 25884357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug treatment clients' readiness for hepatitis C treatment: implications for expanding treatment services in drug and alcohol settings.
    Treloar C; Holt M
    Aust Health Rev; 2008 Aug; 32(3):570-6. PubMed ID: 18666886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Social workers and subbstance-abusing clients: caseload composition and competency self-ratings.
    Amodeo M; Fassler I
    Am J Drug Alcohol Abuse; 2000 Nov; 26(4):629-41. PubMed ID: 11097196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tensions in relation: How peer support is experienced and received in a hepatitis C treatment intervention.
    Bonnington O; Harris M
    Int J Drug Policy; 2017 Sep; 47():221-229. PubMed ID: 28606391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project.
    Gunn RA; Murray PJ; Brennan CH; Callahan DB; Alter MJ; Margolis HS
    Sex Transm Dis; 2003 Apr; 30(4):340-4. PubMed ID: 12671556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: utility of a mixed methods approach.
    Brener L; von Hippel W; von Hippel C; Resnick I; Treloar C
    Drug Alcohol Rev; 2010 Sep; 29(5):491-7. PubMed ID: 20887572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trial: a primary-care-based model for the delivery of anti-viral treatment to injecting drug users infected with hepatitis C.
    Jack K; Willott S; Manners J; Varnam MA; Thomson BJ
    Aliment Pharmacol Ther; 2009 Jan; 29(1):38-45. PubMed ID: 18945252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China.
    Li ZB; Zhang L; Wang J; Huang LP; Zhou ZR; Cao YN; Zhao M; Du J
    Harm Reduct J; 2017 Nov; 14(1):71. PubMed ID: 29096647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engaging primary health care workers in drug and alcohol and mental health interventions: challenges for service delivery in rural and remote Australia.
    Allan J
    Aust J Prim Health; 2010; 16(4):311-8. PubMed ID: 21138699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre.
    Islam MM; Topp L; Conigrave KM; White A; Reid SE; Grummett S; Haber PS; Day CA
    J Subst Abuse Treat; 2012 Dec; 43(4):440-5. PubMed ID: 22938915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pacific healthcare workers and their treatment interventions for Pacific clients with alcohol and drug issues in New Zealand.
    Robinson G; Warren H; Samu K; Wheeler A; Matangi-Karsten H; Agnew F
    N Z Med J; 2006 Jan; 119(1228):U1809. PubMed ID: 16462919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alcohol use reduction program in methadone maintained individuals with hepatitis C virus infection.
    Nyamathi A; de Castro V; McNeese-Smith D; Nyamathi K; Shoptaw S; Marfisee M; Khalilifard F; Cohen A
    J Addict Dis; 2008; 27(4):27-33. PubMed ID: 19042588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Makes you wanna do treatment': benefits of a hepatitis C specialist clinic to clients in Christchurch, New Zealand.
    Brener L; Gray R; Cama EJ; Treloar C
    Health Soc Care Community; 2013 Mar; 21(2):216-23. PubMed ID: 23199074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.